The Centers for Disease Control and Prevention’s advisory group said there were ‘Link’ between rare cases of heart inflammation in adolescents and adults with Pfizer/BioNTech and Moderna COVID-19 vaccines.
In a presentation published on Wednesday The COVID-19 Vaccine Technical Working Group (VaST) has discussed nearly 500 reports of heart inflammation, known as myocardial infarction, among vaccinated adults under the age of 30.
The group’s doctors said his risk of myocardial infarction or pericarditis after vaccination with mRNA-based injections in adolescents and young adults was significantly higher after the second dose. and in males
The Advisory Committee on Immunization (ACIP) will meet this week to assess the possibility of a link between heart conditions and mRNA vaccines.
According to the presentation, there were 484 preliminary reports of myocardial infarction or pericarditis among young people under 30 as of June 11.
So far, the CDC has received 323 confirmations and 148 are still under review.
A total of 309 patients were hospitalized, of which 295 were discharged and 79% had recovered.
Nine patients are still hospitalized. There were two critically ill patients, no data for five patients.
Males were more likely to report heart inflammation after the second dose than women.
As of June 11, 9.1 per million cases of myocardial/pericarditis were reported in women aged 12-17, compared with 66.7 per million among men in that age group.
Moreover Rates for women aged 18-24 and 25-29 were 5.5 per million and 2.6 per million respectively.
Ang Thong men, rates 56.3 per million for the age group 18-24 and 20.4 per million in the 25-29 group.
This type of heart inflammation can be caused by a variety of infections. including the competition of COVID-19 and certain drugs.
With more than 90.6 million young Americans under the age of 30 receiving one or both doses of the Pfizer and Moderna vaccines. This means that only 0.000534 percent of vaccinated people reported such effects.
The ACIP will discuss the benefits of the mRNA vaccine versus the potential risks for adolescents and young adults from heart conditions. according to the agenda of the agency
The group is not expected to vote on any issues regarding the vaccine rollout. But it may issue updates on vaccine safety. chance of myocardial infarction and the risks and benefits of vaccine analysis in adolescents and young adults.
The CDC earlier this month said: Still assessing the risk of such symptoms. and did not confirm a causal relationship between the vaccine and heart problems.
However, the agency stated that An unprecedented number of young men have had a heart attack after a second injection of the COVID-19 mRNA, with more than half of those aged 12 to 24 reporting it.
Dr. Tom Shimabukuro, deputy director of the CDC’s Office of Immunization Safety, said in a presentation that data from one of the agency’s security monitoring systems – Vaccine Safety Datalink (VSD) – suggests rates 12.6 cases per million three weeks after the second shooting in children 12-39 years old
Pfizer, whose vaccine is authorized for use in Americans as young as 12, previously said The company did not observe a higher than normal rate of heart inflammation in the general population.
Moderna said it was unable to determine the cause associated with the heart inflammation case and the vaccine.
Although public health officials in Israel have stated that there is likely a link between vaccination and heart inflammation. But concerns about India’s more infectious ‘delta’ variant have prompted the country to urge children ages 12 to 15 to get vaccinated.